WallStSmart
BLTE

Belite Bio Inc ADR

NASDAQ: BLTE · HEALTHCARE · BIOTECHNOLOGY

$154.50
-2.66% today

Updated 2026-04-29

Market cap
$6.17B
P/E ratio
P/S ratio
EPS (TTM)
$-2.32
Dividend yield
52W range
$56 – $200
Volume
0.2M

Belite Bio Inc ADR (BLTE) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-7.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-118.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+2.3%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+4.1%
2025-08-11
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-27$-0.70-45.1%$149.18$149.18+0.0%
2025-11-18$-0.65-30.7%$116.91$120.37+3.0%
2025-08-11$-0.31+20.5%$69.88$72.73+4.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.48$-0.70-45.1%
2025-09-30$-0.50$-0.65-30.7%
2025-06-30$-0.39$-0.31+20.5%
2025-03-31$-0.37$-0.27+27.0%
2024-12-31$-0.32$-0.32+0.0%
2024-09-30$-0.29$-0.28+3.4%
2024-06-30$-0.26$-0.31-19.2%
2024-03-31$-0.28$-0.27+3.6%
2023-12-31$-0.30$-0.25+16.7%
2023-09-30$-0.32$-0.40-25.0%
2023-06-30$-0.30$-0.26+13.3%
2023-03-31$-0.20$-0.33-65.0%

Frequently asked questions

Has Belite Bio Inc ADR beaten earnings estimates?
Belite Bio Inc ADR has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -7.0% over the last 4 quarters.
How does BLTE stock react to earnings?
BLTE stock has moved an average of +2.3% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.